Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Cash from Investing Activities Growth (3y) (2012 - 2026)

Resmed (RMD) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.99%
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 9.86%
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 18.69%
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -102.03%
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 19.27%
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -7.01%
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -3.15%
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 12.22%
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn 13.17%

Historic Data

Download Data
DateValue
Jun 30, 2026 -102.03%
Mar 31, 2026 -27.34%
Dec 31, 2025 63.25%
Sep 30, 2025 3.66%
Jun 30, 2025 -34.27%
Mar 31, 2025 13.72%
Dec 31, 2024 23.92%
Sep 30, 2024 27.06%
Jun 30, 2024 1.10%
Mar 31, 2024 17.30%
Dec 31, 2023 -11.52%
Sep 30, 2023 -88.88%
Jun 30, 2023 -139.02%
Mar 31, 2023 34.41%
Dec 31, 2022 -186.56%
Sep 30, 2022 -20.96%
Jun 30, 2022 -7.97%
Mar 31, 2022 39.67%
Dec 31, 2021 49.79%
Sep 30, 2021 34.38%